Teva Api India Private Limited - Due diligence report

A 360° intelligence report on Teva Api India Private Limited: trust score, financial health, credit view, compliance, directors, growth and …

2002-04-26 Mumbai, Maharashtra Active Unlisted Active Compliant
Share
TA Teva Api India Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Teva Api India Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Teva Api India Private Limited is assessed as Low Risk with a Trust Score of 82/100. Teva Api India Private Limited is an active private limited indian non-government company incorporated in 2002, operating in the Pharma sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Teva Api India Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
80/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 1.42).
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 80/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 3 court forum(s).
  • 4 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
MUNESHVAR SINGH 01234567 Director 01/04/2018 6 yrs Approved
VINAY KUMAR SHARMA 01234567 Director 01/04/2018 6 yrs Approved
KOMAL MOHNANI 01234567 Director 01/04/2018 6 yrs Approved
Shilpi Shivangi 01234567 Director 01/04/2018 6 yrs Approved
Rohan Yogesh Overseer 01234567 Director 01/04/2018 6 yrs Approved
Arun Thiruselvam 01234567 Director 01/04/2018 6 yrs Approved
  • 6 directors on the board.
  • No disqualified or deactivated DINs.
  • 2 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Teva Pharmaceuticals Finance Netherlands Bv
Subsidiaries
-
Group entities
-
Capital events
18 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Teva Pharmaceuticals Finance Netherlands Bv Holding Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 75
Growth signals & trust indicators
Profit expanded 2.1x year-on-year.
Net margin improved to 24%.
EPFO headcount growing - hiring signal.
Operating for 24+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence79/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view71/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
17 Sep 2025
Last AGM held
Annual general meeting
16 Sep 2025
Director ceased
Rohan Yogesh Overseer
Director ceased
Arun Thiruselvam
18 Jun 2025
Director appointed
Shilpi Shivangi (Company Secretary)
31 Mar 2025
Latest balance sheet
Filed with ROC
12 Mar 2025
Director appointed
Rohan Yogesh Overseer (Director)
Director appointed
Arun Thiruselvam (Director)
17 Aug 2022
Director ceased
NISHANK BHARGAVA
01 Jun 2022
Director appointed
KOMAL MOHNANI (Company Secretary)
19 Aug 2021
Director ceased
VINAY KUMAR SHARMA
31 Jul 2021
Director ceased
RAJESH UMAKANT NAIK
04 Jun 2021
Director appointed
VINAY KUMAR SHARMA (Director)
01 Mar 2021
Director ceased
DEEPAK KUSHALNATH SHUKLA
28 Sep 2020
Director ceased
MUNESHVAR SINGH
28 Mar 2020
Director appointed
MUNESHVAR SINGH (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); board looks stable and experienced.
4 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 18 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Klj Petroplast Limited U24290DL2020PLC371244 New Delhi, Delhi, India
Huntsman Solutions India Private Limited U24290MH2022PTC379027 Thane, Maharashtra, India
Apcotex L99999MH1986PLC039199 Thane, Maharashtra, India
Excel Industries L24200MH1960PLC011807 Mumbai, Maharashtra, India
Aquapharm U24231MH1974PTC017243 Pune, Maharashtra, India
Clariant Igl Specialty Chemicals Private Limited U24290UR2020PTC011365 Kashipur, Uttarakhand, India
Natural Sugar And Allied Industries Limited U72214MH1998PLC121048 Osmanabad, Maharashtra, India
Bvfcl U24123AS2002GOI006786 Namrup, Assam, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Teva Api India Private Limited before audits and certifications: compliance score 80/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Teva Api India Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Teva Api India Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Teva Api India Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Teva Api India Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Teva Api India Private Limited an active company?

Teva Api India Private Limited has MCA status “Active” with a compliance score of 80/100 (Low Risk).

Is Teva Api India Private Limited financially healthy?

Teva Api India Private Limited has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.

Should I do business with Teva Api India Private Limited?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Teva Api India Private Limited?

The ultimate holding entity is Teva Pharmaceuticals Finance Netherlands Bv. 6 active director(s) are on record.

Does Teva Api India Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Teva Api India Private Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 80/100 (Low Risk).

Is it risky to lend to Teva Api India Private Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.